Page last updated: 2024-09-03

y 27632 and Chondrosarcoma

y 27632 has been researched along with Chondrosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bygdell, J; Fernández-Echevarría, C; Lammi, MJ; Marcellino, D; Piltti, J	1

Other Studies

1 other study(ies) available for y 27632 and Chondrosarcoma

Article	Year
Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells. Scientific reports, 2017, 06-16, Volume: 7, Issue:1 Topics: Amides; Biomarkers; Cell Line, Tumor; Chondrosarcoma; Collagen Type II; Humans; Protein Kinase Inhibitors; Proteomics; Pyridines; rho-Associated Kinases; S100 Proteins; Time-Lapse Imaging	2017

Article

Year

Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells.

Scientific reports, 2017, 06-16, Volume: 7, Issue:1

Topics: Amides; Biomarkers; Cell Line, Tumor; Chondrosarcoma; Collagen Type II; Humans; Protein Kinase Inhibitors; Proteomics; Pyridines; rho-Associated Kinases; S100 Proteins; Time-Lapse Imaging

2017